Search details
1.
Effect of early tumor response on the health-related quality of life among patients on second-line chemotherapy for advanced gastric cancer in the ABSOLUTE trial.
Gastric Cancer
; 24(2): 467-476, 2021 Mar.
Article
in English
| MEDLINE | ID: mdl-33136231
2.
S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin as first-line therapy in patients with advanced gastric cancer (SOLAR): a randomised, open-label, phase 3 trial.
Lancet Oncol
; 21(8): 1045-1056, 2020 08.
Article
in English
| MEDLINE | ID: mdl-32682457
3.
Meta-analysis of two randomized phase III trials (TCOG GI-0801 and ECRIN TRICS) of biweekly irinotecan plus cisplatin versus irinotecan alone as second-line treatment for advanced gastric cancer.
Gastric Cancer
; 23(1): 160-167, 2020 01.
Article
in English
| MEDLINE | ID: mdl-31309387
4.
Association between the findings of metachronous secondary primary malignancies and the number of Lugol-voiding lesions.
Dis Esophagus
; 33(9)2020 Sep 04.
Article
in English
| MEDLINE | ID: mdl-32052025
5.
Association between macrocytosis and metachronous squamous cell carcinoma of the esophagus after endoscopic resection in men with early esophageal squamous cell carcinoma.
Esophagus
; 17(2): 149-158, 2020 04.
Article
in English
| MEDLINE | ID: mdl-31281950
6.
Peritoneal metastasis as a predictive factor for nab-paclitaxel in patients with pretreated advanced gastric cancer: an exploratory analysis of the phase III ABSOLUTE trial.
Gastric Cancer
; 22(1): 155-163, 2019 01.
Article
in English
| MEDLINE | ID: mdl-29855738
7.
A phase I study of S-1 in combination with nab-paclitaxel in patients with unresectable or recurrent gastric cancer.
Gastric Cancer
; 20(2): 350-357, 2017 Mar.
Article
in English
| MEDLINE | ID: mdl-27189323
8.
A phase II study of 5-fluorouracil/L-leucovorin/oxaliplatin (mFOLFOX6) in Japanese patients with metastatic or unresectable small bowel adenocarcinoma.
Int J Clin Oncol
; 22(5): 905-912, 2017 Oct.
Article
in English
| MEDLINE | ID: mdl-28536826
9.
Randomized phase II study of second-line chemotherapy with the best available 5-fluorouracil regimen versus weekly administration of paclitaxel in far advanced gastric cancer with severe peritoneal metastases refractory to 5-fluorouracil-containing regimens (JCOG0407).
Gastric Cancer
; 19(3): 902-10, 2016 Jul.
Article
in English
| MEDLINE | ID: mdl-26386560
10.
Correction to: Effect of early tumor response on the health-related quality of life among patients on second-line chemotherapy for advanced gastric cancer in the ABSOLUTE trial.
Gastric Cancer
; 24(2): 477-478, 2021 Mar.
Article
in English
| MEDLINE | ID: mdl-33300101
11.
A phase II study of bevacizumab with modified OPTIMOX1 as first-line therapy for metastatic colorectal cancer: the TCOG-GI 0802 study.
Invest New Drugs
; 33(4): 954-62, 2015 Aug.
Article
in English
| MEDLINE | ID: mdl-25937430
12.
A phase I/II study of XELIRI plus bevacizumab as second-line chemotherapy for Japanese patients with metastatic colorectal cancer (BIX study).
Oncologist
; 19(11): 1131-2, 2014 Nov.
Article
in English
| MEDLINE | ID: mdl-25280489
13.
Multicenter feasibility study of combination therapy with fluorouracil, leucovorin and paclitaxel (FLTAX) for peritoneal disseminated gastric cancer with massive ascites or inadequate oral intake.
Jpn J Clin Oncol
; 42(9): 787-93, 2012 Sep.
Article
in English
| MEDLINE | ID: mdl-22782960
14.
Phase II study of bolus 5-fluorouracil and leucovorin combined with weekly paclitaxel as first-line therapy for advanced gastric cancer.
Oncology
; 81(5-6): 291-7, 2011.
Article
in English
| MEDLINE | ID: mdl-22134040
15.
Impacts of fluorouracil-metabolizing enzymes on the outcomes of patients treated with S-1 alone or S-1 plus cisplatin for first-line treatment of advanced gastric cancer.
Int J Cancer
; 126(1): 162-70, 2010 Jan 01.
Article
in English
| MEDLINE | ID: mdl-19588501
16.
Clinical significance of evaluating primary lesions in patients with gastric cancer who receive chemotherapy.
Gastric Cancer
; 13(1): 36-42, 2010 Mar.
Article
in English
| MEDLINE | ID: mdl-20373074
17.
[Three cases of radiotherapy combined with S-1 and mitomycin C for anal canal squamous cell carcinomas].
Gan To Kagaku Ryoho
; 37(13): 2941-3, 2010 Dec.
Article
in Japanese
| MEDLINE | ID: mdl-21160276
18.
Second-line chemotherapy with biweekly paclitaxel after failure of fluoropyrimidine-based treatment in patients with advanced or recurrent gastric cancer: a report from the gastrointestinal oncology group of the Tokyo cooperative oncology group, TCOG GC-0501 trial.
Jpn J Clin Oncol
; 39(11): 713-9, 2009 Nov.
Article
in English
| MEDLINE | ID: mdl-19812061
19.
Endoscopic submucosal dissection (two-point fixed ESD) for early esophageal cancer.
Dig Endosc
; 21(3): 176-9, 2009 Jul.
Article
in English
| MEDLINE | ID: mdl-19691765
20.
Docetaxel plus cisplatin and S-1 versus cisplatin and S-1 in patients with advanced gastric cancer (JCOG1013): an open-label, phase 3, randomised controlled trial.
Lancet Gastroenterol Hepatol
; 4(7): 501-510, 2019 07.
Article
in English
| MEDLINE | ID: mdl-31101534